微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 62.34% | -3.56% | -0.69% | 46/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 62.78% | -1.11% | -2.37% | 45/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 64.3% | 4.38% | -0.75% | 40/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 64.79% | -4.32% | 0.22% | 42/160 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 64.65% | -5.39% | 1.84% | 40/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 63.48% | -7.92% | 3.05% | 49/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 61.6% | -7.34% | -9.03% | 51/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 67.71% | -6.46% | -0.9% | 44/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 68.33% | -6.77% | -0.88% | 43/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 68.94% | -4.47% | 3.7% | 44/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 66.48% | -7.85% | -8.16% | 44/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 72.39% | -0.44% | -1.24% | 37/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 73.29% | 2% | 1.57% | 32/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 72.16% | 0.75% | 0.03% | 35/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 72.14% | 2% | -0.78% | 29/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 72.7% | 3.22% | 1.51% | 35/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-06-30 | 71.62% | 2% | 1.69% | 29/160 | 54.32% | 泽璟制药 | 99.96% | 行业排名> |
| 2019-12-31 | 70.43% | 0.93% | 0.93% | 39/160 | -1204.25% | 微芯生物 | 95.14% | 行业排名> |
| 2018-12-31 | 69.78% | 18.95% | 18.95% | 37/160 | -205.91% | 多瑞医药 | 95.59% | 行业排名> |
| 2017-12-31 | 58.66% | 2% | 2% | 47/160 | 52.58% | 微芯生物 | 95.81% | 行业排名> |